Glial Fibrillary Acidic Protein Astrocytopathy: Review of Pathogenesis, Imaging Features, and Radiographic Mimics

References

1. 1.↵
   1. Fang B,
   2. McKeon A,
   3. Hinson SR, et al

   . Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 2016;73:1297–307 doi:10.1001/jamaneurol.2016.2549 pmid:27618707

   CrossRefPubMed
2. 2.↵
   1. Liao H,
   2. Chen Q,
   3. Zhang M, et al

   . MRI features and evolution of autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective cross-sectional and longitudinal study. Mult Scler Relat Disord 2022;58:103512 doi:10.1016/j.msard.2022.103512 pmid:35066273

   CrossRefPubMed
3. 3.↵
   1. Fu CC,
   2. Huang L,
   3. Xu LF, et al

   . Serological biomarkers in autoimmune GFAP astrocytopathy. Front Immunol 2022;13:957361 doi:10.3389/fimmu.2022.957361 pmid:35983033

   CrossRefPubMed
4. 4.↵
   1. Gravier-Dumonceau A,
   2. Ameli R,
   3. Rogemond V, et al

   . Glial fibrillary acidic protein autoimmunity: a French cohort study. Neurology 2022;98:e653–e668 doi:10.1212/WNL.0000000000013087 pmid:34799461

   CrossRefPubMed
5. 5.↵
   1. Iorio R,
   2. Damato V,
   3. Evoli A, et al

   . Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients. J Neurol Neurosurg Psychiatry 2018;89:138–46 doi:10.1136/jnnp-2017-316583 pmid:28951498

   Abstract/FREE Full Text
6. 6.↵
   1. Flanagan EP,
   2. Hinson SR,
   3. Lennon VA, et al

   . Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 2017;81:298–309 doi:10.1002/ana.24881 pmid:28120349

   CrossRefPubMed
7. 7.↵
   1. Long Y,
   2. Liang J,
   3. Xu H, et al

   . Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients. Eur J Neurol 2018;25:477–83 doi:10.1111/ene.13531 pmid:29193473

   CrossRefPubMed
8. 8.↵
   1. Xiao J,
   2. Chen X,
   3. Shang K, et al

   . Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy. J Neuroimmunol 2021;360:577718 doi:10.1016/j.jneuroim.2021.577718 pmid:34600199

   CrossRefPubMed
9. 9.↵
   1. Kunchok A,
   2. Zekeridou A,
   3. McKeon A

   . Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol 2019;32:452–58 doi:10.1097/WCO.0000000000000676 pmid:30724768

   CrossRefPubMed
10. 10.↵
    1. Greco G,
    2. Masciocchi S,
    3. Diamanti L, et al

    . Visual system involvement in glial fibrillary acidic protein astrocytopathy: two case reports and a systematic literature review. Neurol Neuroimmunol Neuroinflamm 2023;10:e200146 doi:10.1212/NXI.0000000000200146

    Abstract/FREE Full Text
11. 11.↵
    1. Kimura A,
    2. Takekoshi A,
    3. Yoshikura N, et al

    . Clinical characteristics of autoimmune GFAP astrocytopathy. J Neuroimmunol 2019;332:91–98 doi:10.1016/j.jneuroim.2019.04.004 pmid:30991306

    CrossRefPubMed
12. 12.↵
    1. Qin N,
    2. Wu X,
    3. Wang J, et al

    . Case report: autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as tuberculous meningitis. Front Neurol 2023;14:1123603 doi:10.3389/fneur.2023.1123603 pmid:36970528

    CrossRefPubMed
13. 13.↵
    1. Iwami K,
    2. Nomura T,
    3. Seo S, et al

    . Autoimmune glial fibrillary acidic protein astrocytopathy presenting with area postrema syndrome-like symptoms without medulla oblongata lesions. Neuroimmunomodulation 2022;29:433–38 doi:10.1159/000524344 pmid:35421859

    CrossRefPubMed
14. 14.↵
    1. Yang Z,
    2. Wang KK

    . Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci 2015;38:364–74 doi:10.1016/j.tins.2015.04.003 pmid:25975510

    CrossRefPubMed
15. 15.↵
    1. Kimura A,
    2. Takemura M,
    3. Yamamoto Y, et al

    . Cytokines and biological markers in autoimmune GFAP astrocytopathy. J Neuroimmunol 2019;334:576999 doi:10.1016/j.jneuroim.2019.576999 pmid:31254929

    CrossRefPubMed
16. 16.↵
    1. Cheng P,
    2. Huang W,
    3. Yang M, et al

    . Autoimmune GFAP astrocytopathy after viral encephalitis: a case report of bimodal overlapping encephalitis. Front Immunol 2023;14:1258048 doi:10.3389/fimmu.2023.1258048 pmid:37781407

    CrossRefPubMed
17. 17.↵
    1. Mader S,
    2. Kumpfel T,
    3. Meinl E

    . Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond. Curr Opin Neurol 2022;35:427–35 doi:10.1097/WCO.0000000000001052 pmid:35674086

    CrossRefPubMed
18. 18.↵
    1. Zhang YM,
    2. Liu S,
    3. Liu TT, et al

    . GFAP antibody-negative myelitis with high similarity to autoimmune GFAP astrocytopathy: a case report. Neurol Sci 2022;43:5659–61 doi:10.1007/s10072-022-06127-3 pmid:35585438

    CrossRefPubMed
19. 19.↵
    1. Huang J,
    2. Huang W,
    3. Zhou R, et al

    . Detection and significance of glial fibrillary acidic protein antibody in autoimmune astocytopathy and related diseases. Ann Transl Med 2023;11:288 doi:10.21037/atm-19-330 pmid:37090053

    CrossRefPubMed
20. 20.↵
    1. Yang X,
    2. Liang J,
    3. Huang Q, et al

    . Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases. Neuroimmunomodulation 2017;24:113–19 doi:10.1159/000479948 pmid:28922662

    CrossRefPubMed
21. 21.↵
    1. Pons-Escoda A,
    2. Naval-Baudin P,
    3. Velasco R, et al

    . Imaging of lymphomas involving the CNS. AJNR Am J Neuroradiol 2023;44:358–66 doi:10.3174/ajnr.A7795 pmid:36822829

    Abstract/FREE Full Text
22. 22.↵
    1. Paul SA,
    2. Roy D,
    3. Mondal GP, et al

    . Primary angiitis of central nervous system - a challenging diagnosis. J Neuroimmunol 2022;366:577844 doi:10.1016/j.jneuroim.2022.577844 pmid:35299076

    CrossRefPubMed
23. 23.↵
    1. Shan F,
    2. Long Y,
    3. Qiu W

    . Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol 2018;9:2802 doi:10.3389/fimmu.2018.02802 pmid:30568655

    CrossRefPubMed
24. 24.↵
    1. Lan W,
    2. Li J,
    3. Ai P, et al

    . Autoimmune glial fibrillary acidic protein astrocytopathy: clinical analysis and review of 15 cases. Acta Neurol Belg 2023;123:1465–79 doi:10.1007/s13760-023-02268-0 pmid:37079256

    CrossRefPubMed
25. 25.↵
    1. Xiao J,
    2. Zhang SQ,
    3. Chen X, et al

    . Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD and AQP4-IgG(+) NMOSD mimicking intracranial infection as the initial manifestation. Mult Scler Relat Disord 2022;66:104057 doi:10.1016/j.msard.2022.104057 pmid:35870369

    CrossRefPubMed
26. 26.↵
    1. Sechi E,
    2. Cacciaguerra L,
    3. Chen JJ, et al

    . Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol 2022;13:885218 doi:10.3389/fneur.2022.885218 pmid:35785363

    CrossRefPubMed
27. 27.↵
    1. Dutra BG,
    2. da Rocha AJ,
    3. Nunes RH, et al

    . Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis. Radiographics 2018;38:169–93 doi:10.1148/rg.2018170141 pmid:29320331

    CrossRefPubMed
28. 28.↵
    1. Yang X,
    2. Xu H,
    3. Ding M, et al

    . Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies. Front Neurol 2018;9:251 doi:10.3389/fneur.2018.00251 pmid:29755396

    CrossRefPubMed
29. 29.↵
    1. Shrestha NM,
    2. Acharya N,
    3. Desar R

    . Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS syndrome). Case Rep Neurol Med 2023;2023:5811243 doi:10.1155/2023/5811243 pmid:37520771

    CrossRefPubMed
30. 30.↵
    1. Sudhakar V,
    2. Gersey Z,
    3. Polster SP, et al

    . Supratentorial lymphocytic inflammation with parenchymal perivascular enhancement responsive to steroids. Surg Neurol Int 2021;12:327 doi:10.25259/SNI_355_2021 pmid:34345468

    CrossRefPubMed
31. 31.↵
    1. Roschewski M,
    2. Wilson WH

    . Lymphomatoid granulomatosis. Cancer J 2012;18:469–74 doi:10.1097/PPO.0b013e31826c5e19 pmid:23006954

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Chen D,
    2. Zhou J,
    3. Lu W, et al

    . Lymphomatoid granulomatosis with the central nervous system involvement as the main manifestation. BMC Neurol 2023;23:208 doi:10.1186/s12883-023-03257-9 pmid:37248444

    CrossRefPubMed
33. 33.↵
    1. Vandermeersch D,
    2. Mahsouli A,
    3. Willemart M, et al

    . Intravascular large cell B lymphoma presenting as central nervous system pseudo-vasculitis: a rare diagnostic challenge. Neuroradiol J 2023;19714009231212351 doi:10.1177/19714009231212351 pmid:37933603

    CrossRefPubMed
34. 34.↵
    1. Lauw MIS,
    2. Lucas CG,
    3. Ohgami RS, et al

    . Primary central nervous system lymphomas: a diagnostic overview of key histomorphologic, immunophenotypic, and genetic features. Diagnostics (Basel) 2020;10:1076 doi:10.3390/diagnostics10121076

    CrossRefPubMed
35. 35.↵
    1. Nizamutdinov D,
    2. Patel NP,
    3. Huang JH, et al

    . Intravascular lymphoma in the CNS: options for treatment. Curr Treat Options Neurol 2017;19:35 doi:10.1007/s11940-017-0471-4 pmid:28831736

    CrossRefPubMed
36. 36.↵
    1. Bradshaw MJ,
    2. Pawate S,
    3. Koth LL, et al

    . Neurosarcoidosis: pathophysiology, diagnosis, and treatment. Neurol Neuroimmunol Neuroinflamm 2021;8:e1084 doi:10.1212/NXI.0000000000001084

    Abstract/FREE Full Text
37. 37.↵
    1. Ungprasert P,
    2. Matteson EL

    . Neurosarcoidosis. Rheum Dis Clin North Am 2017;43:593–606 doi:10.1016/j.rdc.2017.06.008 pmid:29061245

    CrossRefPubMed
38. 38.↵
    1. Beuker C,
    2. Schmidt A,
    3. Strunk D, et al

    . Primary angiitis of the central nervous system: diagnosis and treatment. Ther Adv Neurol Disord 2018;11:1756286418785071 doi:10.1177/1756286418785071 pmid:30034536

    CrossRefPubMed
39. 39.↵
    1. Salvarani C,
    2. Brown RD, Jr.,
    3. Calamia KT, et al

    . Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007;62:442–51 doi:10.1002/ana.21226 pmid:17924545

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Salvarani C,
    2. Brown RD, Jr.,
    3. Calamia KT, et al

    . Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels. Medicine (Baltimore) 2008;87:264–71 doi:10.1097/MD.0b013e31818896e1 pmid:18794709

    CrossRefPubMed